Sponsor: Synthego

Where: B21

Synthego is a genome engineering company that enables life science research and the development of new therapeutics and genomic medicines. Our mission is to increase access to CRISPR-based technologies and therapeutics for all scientists and patients. With unparalleled CRISPR expertise, state-of-the-art cell engineering and GMP capabilities, and a continuum of product offerings, Synthego supports the development of new therapeutics and genomic medicines at every step, from R&D through IND submission to first-in-human clinical trials.

Thu19  Dec04:20pm(5 mins)	High-Throughput Genome Editing for Disease Models
	Room: Hall 1C